 |
 |

Rethinking Multiple Sclerosis
Arch Neurol. 2001;58:30-32.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
THE STUDY of multiple sclerosis (MS) has been one of the more active
and rewarding areas of neurological research in the last quarter of the 20th
century. Viewed as the pathological consequence of a partially dysregulated
immune response turned against certain myelin components, MS has recently
joined the growing forefront of neurological illnesses for which disease-modifying
treatments are now available. Yet, the continued advancement of better and
more effective therapies relies on a better understanding of the pathological
basis of MS, especially in relation to its associated neurological consequences.
The most apparent aspects of MS in most individuals are relapses and
a subsequent irreversible worsening (progression) of neurological deficits.
Generally, clinical relapses have been considered to be associated with sporadic
focal inflammatory events within clinically eloquent areas of the brain and
spinal cord, while the sustained progression of clinical disability has been
associated with accumulated, relapse-associated, focal myelin and axonal . . . [Full Text of this Article]
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
What Causes Multiple Sclerosis to Worsen?
Phillips
Arch Neurol 2007;64:167-168.
FULL TEXT
|